ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01726062
Recruitment Status : Completed
First Posted : November 14, 2012
Last Update Posted : May 14, 2018
Sponsor:
Collaborators:
Memorial Hermann Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Angela Stotts, The University of Texas Health Science Center, Houston

Brief Summary:
A randomized, controlled, parallel group design will be used to test whether a Secondhand Smoke Exposure program initiated in the hospital and completed in the home using motivational interviewing plus motivational incentives (MI+) is more effective than Conventional Care (CC) with Neonatal Incentives Care Unit Infants' parents.

Condition or disease Intervention/treatment Phase
Exposure to Secondhand Smoke in Neonatal Infants Behavioral: Motivational Interviewing plus Incentives Behavioral: Conventional Care (CC) Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 360 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes (The Baby's Breath II Project)
Actual Study Start Date : August 2012
Actual Primary Completion Date : January 30, 2018
Actual Study Completion Date : January 30, 2018

Arm Intervention/treatment
Experimental: Motivational Interviewing plus Incentives Behavioral: Motivational Interviewing plus Incentives
  1. Two hospital-based, face-to-face MI+ sessions
  2. Two home-based MI+ sessions
  3. Attendance at each session and for the establishment of a household smoking ban at two timepoints post-discharge

Conventional Care (CC) Behavioral: Conventional Care (CC)
Participants in this arm will receive brochures and a brief information meeting in the NICU.




Primary Outcome Measures :
  1. Infant Second-Hand Smoke Exposure via Urine Cotinine [ Time Frame: Follow-up visit 4 months post-treatment ]
    Infant Second-Hand Smoke Exposure (SHSe) measures will be determined via urine cotinine.


Secondary Outcome Measures :
  1. Secondhand Smoke Exposure outcomes [ Time Frame: Change from Baseline to the 4 months post-treatment followup ]
    Primary caregiver reports via the Timeline Follow-Back and household air nicotine monitors. Number of cigarettes smoked outdoors vs. indoor and the implementation of household smoking bans will also be assessed. Primary caregivers will complete the SHSe related interviews and self-report questionnaires. Primary caregivers who are smokers will complete measures related to smoking and smoking cessation.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Have an infant that is at least 1 week prior to the estimated date of hospital discharge in the NICU at Children's Memorial Hermann Hospital (CMHH)
  • Report at least one person living in the home who smokes
  • Agree to attend intervention sessions and to invite other household members
  • Live within 50 miles of our center
  • Have access to a telephone.

Exclusion Criteria:

  • Severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol
  • Inability to read, write, and speak English or Spanish
  • Inability or unwillingness to provide signed consent for participation
  • Inability or unwillingness to meet study requirements, including home visits for data collection and intervention purposes.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01726062


Locations
United States, Texas
Children's Memorial Hermann Hospital
Houston, Texas, United States, 77030
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
Memorial Hermann Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Angela Stotts, PhD University of Texas at Houston Family and Community Medicine

Responsible Party: Angela Stotts, Associate Professor - Family Medicine, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT01726062     History of Changes
Other Study ID Numbers: HSC-MS-11-0641
1R01HL107404-01A1 ( U.S. NIH Grant/Contract )
First Posted: November 14, 2012    Key Record Dates
Last Update Posted: May 14, 2018
Last Verified: May 2018

Keywords provided by Angela Stotts, The University of Texas Health Science Center, Houston:
Motivational Incentives
Motivational Interviewing
Secondhand Smoke
Neonatal Intensive Care Unit
NICU
High respiratory risk infants
Low birth weight infants
Environmental Tobacco Smoke
Smoking
Contingency management
Infants
Children